The Defense Advanced Research Projects Agency (DARPA) is creepy enough. Now Biden wants to create a health counterpart called HARPA. Close collaboration between the two is envisioned. A merger of “national security” and “health security,” what could go wrong? From Whitney Webb at lewrockwell.com:
A “new” proposal by the Biden administration to create a health-focused federal agency modeled after DARPA is not what it appears to be. Promoted as a way to “end cancer,” this resuscitated “health DARPA” conceals a dangerous agenda.
[April 28, 2020], President Biden was widely praised in mainstream and health-care–focused media for his call to create a “new biomedical research agency” modeled after the U.S. military’s “high-risk, high-reward” Defense Advanced Research Projects Agency, or DARPA. As touted by the president, the agency would seek to develop “innovative” and “breakthrough” treatments for cancer, Alzheimer’s disease and diabetes, with a call to “end cancer as we know it.”
Far from “ending cancer” in the way most Americans might envision it, the proposed agency would merge “national security” with “health security” in such a way as to use both physical and mental health “warning signs” to prevent outbreaks of disease or violence before they occur. Such a system is a recipe for a technocratic “pre-crime” organization with the potential to criminalize both mental and physical illness as well as “wrongthink.”
The Biden administration has asked Congress for $6.5 billion to fund the agency, which would be largely guided by Biden’s recently confirmed top science adviser, Eric Lander.
Lander, formerly the head of the Silicon Valley-dominated Broad Institute, has been controversial for his ties to eugenicist and child sex trafficker Jeffrey Epstein and his relatively recent praise for James Watson, an overtly racist eugenicist. Despite that, Lander is set to be confirmed by the Senate and Congress and is reportedly significantly enthusiastic about the proposed new “health DARPA.”
This new agency, set to be called ARPA-H or HARPA, would be housed within the National Institutes of Health (NIH) and would raise the NIH budget to over $51 billion. Unlike other agencies at NIH, ARPA-H would differ in that the projects it funds would not be peer reviewed prior to approval; instead, hand-picked program managers would make all funding decisions. Funding would also take the form of milestone-driven payments instead of the more traditional multiyear grants.
ARPA-H will likely heavily fund and promote mRNA vaccines as one of the “breakthroughs” that will cure cancer. Some of the mRNA vaccine manufacturers that have produced some of the most widely used COVID-19 vaccines, such as the Pfizer/BioNTech vaccine, stated just last month that “cancer is the next problem to tackle with mRNA tech” post-COVID.